|
KMID : 0984720040360020083
|
|
Infection and Chemotherapy
2004 Volume.36 No. 2 p.83 ~ p.91
|
|
|
Efficacies of Teicoplanin in Patients with Febrile Neutropenia
|
|
Lee Dong-Gun
Yim Dong-Seok
Choi Su-Mi
Park Sun-Hee
Yoo Jin-Hong
Choi Jung-Hyun
Min Woo-Sung
Shin Wan-Shik
Kim Choon-Choo
|
|
|
Abstract
|
|
|
Background : This study was done to elucidate the efficacy of teicoplanin as the empirical treatment for febrile neutropenia.
Methods : Patients were randomized to two groups according to pharmaceutical company (company A or B). Total of 49 patients (A, 27; B, 22) with neutropenic fever were studied prospectively for 6 months (Jul. 2003-Dec. 2003). Patients received 400 mg i.v. once, then 200 mg i.v. once daily.
Results : Groups were matched for all demographic variables. Most of the patients were concurrently receiving nephrotoxic drugs. Gram positive microorganisms were isolated in 8 patients for A and 7 patients for B. Resistance rate against teicoplanin was 22.2% in A and 28.6% in B (P=1.0; 0.61 < 95% confidence interval [CI] < 1.95). Among the patients with microbiologically documented infection, clinical cure or improvement was seen in 4 (50%) of 8 patients for A and 4 (57.1%) of 7 patients for B (P=1.00; 0.29 <95%Cl <2.60). Bacteriologic efficacy was assessed as follows; elimination in 5 (55.6%), elimination with relapse in 2 (22.2%), resistance in 2 (22.2%) out of 9 gram-positive bacteria for A and 5 (51.4%), 0 (0.0%), 2 (28.6%) out of 7 bacteria for B, respectively (P=0.28). There were no significant differences in duration of fever, duration of use of teicoplanin, and overall mortality. The incidence of nephrotoxicity and ototoxicity was not significant.
Conclusion : For using teicoplanin as the empirical therapy for febrile neutropenia, the rate of clinical, microbiological response, and nephrotoxicity was 53.3%, 62.5%, and 16.3% respectively with no significant differences between the 2 preparations of teicoplanin. Supplementary evaluation on the adequate dose and duration of eicoplanin may be required.
|
|
|
KEYWORD
|
|
|
Neutropenia, Teicoplanin, Treatment outcome
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|
|